TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group.
about
TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group.
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
TRIBE-2: a phase III, randomiz ...... er patients by the GONO group.
@ast
TRIBE-2: a phase III, randomiz ...... er patients by the GONO group.
@en
type
label
TRIBE-2: a phase III, randomiz ...... er patients by the GONO group.
@ast
TRIBE-2: a phase III, randomiz ...... er patients by the GONO group.
@en
prefLabel
TRIBE-2: a phase III, randomiz ...... er patients by the GONO group.
@ast
TRIBE-2: a phase III, randomiz ...... er patients by the GONO group.
@en
P2093
P2860
P50
P1433
P1476
TRIBE-2: a phase III, randomiz ...... cer patients by the GONO group
@en
P2093
Carlotta Antoniotti
Chiara Valsuani
Daniele Santini
Emiliano Tamburini
Federica Marmorino
Giacomo Allegrini
Gianluca Masi
Gianluca Tomasello
Giuseppe Aprile
P2860
P2888
P356
10.1186/S12885-017-3360-Z
P407
P50
P577
2017-06-09T00:00:00Z
P6179
1085967974